Model and experimental data strongly suggest testing TEVGs until scaffold has biodegraded
Randomized, controlled clinical trials are needed to answer questions regarding when and with whom to use the device.
Data from The Pediatric Heart Network Normal Echocardiogram Database show interobserver variability, especially in younger and smaller patients.
Case study shows success for medical therapy and MRI monitoring of a cardiac rhabdomyoma.
Race, type of insurance and severity of disease affect likelihood of experiencing a lapse in care for CHD patients younger than 5 years.
The world’s busiest hybrid palliation team is working to improve outcomes by analyzing what happens between surgeries, including readmissions and other serious events.
